https://doi.org/10.1016/j.nut.2014.11.018
K
Ken Sato
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
528
Papers
6.5K
Citations
43
h-index
148
i10-index
Ken Sato is an academic researcher from Okayama University of Science. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Hepatitis C virus research & Liver Disease and Transplantation. The author has an h-index of 43, co-authored 449 publications.
ORCID: 0000-0002-3202-7983Papers by this author
worksVitamin E has a beneficial effect on nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials
2014 · Nutrition · 197 citations
A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)
2019 · CHEST Journal · 36 citations
https://doi.org/10.1016/j.chest.2019.01.011
Serum and urinary concentrations of heparan sulfate in patients with diabetic nephropathy
1999 · Kidney International · 32 citations
https://doi.org/10.1046/j.1523-1755.1999.00591.x
Integrative roles of transforming growth factor-α in the cytoprotection mechanisms of gastric mucosal injury
2006 · BMC Gastroenterology · 14 citations
https://doi.org/10.1186/1471-230x-6-22
Ipragliflozin-induced improvement of liver steatosis in obese mice may involve sirtuin signaling
2020 · World Journal of Hepatology · 14 citations
https://doi.org/10.4254/wjh.v12.i7.350
End-tidal capnographic monitoring during flexible bronchoscopy under fentanyl and midazolam sedation
2021 · Annals of Palliative Medicine · 12 citations
https://doi.org/10.21037/apm-21-1009
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat